Anika Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0352551081
USD
20.16
0.97 (5.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
32.61
29.61
30.61
27.82
28.22
26.17
30.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
32.61
29.61
30.61
27.82
28.22
26.17
30.60
Raw Material Cost
11.37
10.62
11.44
12.23
13.86
11.49
13.48
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
10.95
17.77
12.08
11.87
12.23
12.91
11.32
Other Expenses
0.73
0.67
0.65
0.69
0.63
0.61
0.65
Total Expenditure (Excl Depreciation)
29.66
35.10
29.97
31.05
32.40
30.45
31.31
Operating Profit (PBDIT) excl Other Income
3
-5.5
0.6
-3.2
-4.2
-4.3
-0.7000000000000001
Other Income
0.43
0.67
0.12
1.00
0.21
0.41
0.74
Operating Profit (PBDIT)
4.88
-3.41
2.08
-0.84
-2.47
-2.28
1.47
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
21.24
19.00
19.18
15.58
14.36
14.68
17.12
Depreciation
1.50
1.41
1.32
1.40
1.50
1.59
1.44
Profit Before Tax
3.38
-4.82
0.76
-2.24
-3.97
-3.87
0.04
Tax
0.07
0.23
-1.04
0.94
0.68
0.09
2.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3.31
-5.06
1.80
-3.17
-4.65
-3.96
-2.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3.31
-5.06
1.80
-3.17
-4.65
-3.96
-2.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3.31
-5.06
1.80
-3.17
-4.65
-3.96
-2.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
137.28
133.90
143.47
146.81
147.67
148.40
153.99
Earnings per share (EPS)
0.24
-0.37
0.02
-0.16
-0.28
-0.34
-1.5
Diluted Earnings per share
0.24
-0.37
0.02
-0.16
-0.28
-0.34
-1.5
Operating Profit Margin (Excl OI)
9.06%
-18.53%
2.11%
-11.62%
-14.81%
-16.37%
-2.31%
Gross Profit Margin
14.98%
-11.53%
6.8%
-3.01%
-8.74%
-8.7%
4.81%
PAT Margin
10.15%
-17.07%
5.88%
-11.41%
-16.47%
-15.13%
-8.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 10.14% vs -3.27% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 164.71% vs -383.33% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 209.76% vs -305.00% in Mar 2026

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Anika Therapeutics, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
32.61
19.25
13.36
69.40%
Other Operating Income
0.00
0.00
0.00
Total Operating income
32.61
19.25
13.36
69.40%
Raw Material Cost
11.37
3.52
7.85
223.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
1.74
-1.74
-100.00%
Selling and Distribution Expenses
10.95
18.90
-7.95
-42.06%
Other Expenses
0.73
0.39
0.34
87.18%
Total Expenditure (Excl Depreciation)
29.66
28.05
1.61
5.74%
Operating Profit (PBDIT) excl Other Income
2.95
-8.80
11.75
133.52%
Other Income
0.43
0.35
0.08
22.86%
Operating Profit (PBDIT)
4.88
-7.82
12.70
162.40%
Interest
0.00
1.74
-1.74
-100.00%
Exceptional Items
0.00
-0.43
0.43
100.00%
Gross Profit (PBDT)
21.24
15.73
5.51
35.03%
Depreciation
1.50
0.63
0.87
138.10%
Profit Before Tax
3.38
-10.62
14.00
131.83%
Tax
0.07
-0.01
0.08
800.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
3.31
-10.61
13.92
131.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3.31
-10.61
13.92
131.20%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3.31
-10.61
13.92
131.20%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
137.28
-23.17
160.45
692.49%
Earnings per share (EPS)
0.24
-0.35
0.59
168.57%
Diluted Earnings per share
0.24
-0.35
0.59
168.57%
Operating Profit Margin (Excl OI)
9.06%
-45.73%
0.00
54.79%
Gross Profit Margin
14.98%
-51.92%
0.00
66.90%
PAT Margin
10.15%
-55.12%
0.00
65.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3.26 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 10.14% vs -3.27% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.60% vs -32.70% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.33 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 164.71% vs -383.33% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 171.74% vs -4,500.00% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.45 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 209.76% vs -305.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 266.67% vs -222.73% in Jun 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.06%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025